{"id":502,"date":"2015-04-07T13:27:01","date_gmt":"2015-04-07T13:27:01","guid":{"rendered":"https:\/\/blogs.bmj.com\/jnnp\/?p=502"},"modified":"2015-04-07T13:27:01","modified_gmt":"2015-04-07T13:27:01","slug":"temozolomide-reduces-risk-of-seizures-in-low-grade-glioma","status":"publish","type":"post","link":"https:\/\/blogs.bmj.com\/jnnp\/2015\/04\/07\/temozolomide-reduces-risk-of-seizures-in-low-grade-glioma\/","title":{"rendered":"Temozolomide reduces risk of seizures in low grade glioma!"},"content":{"rendered":"

Low grade gliomas are associated with a higher frequency of seizures.\u00a0 While antieplipetic medications are utilized to reduced seizure frequency, in this issue of JNNP temozolomide was also associated with a a significant reduction in seizure frequency.\u00a0 Perhaps temozolomide should be added to therapy of LGGs with intractable seizures.<\/p>\n

 <\/p>\n

Read more at http:\/\/jnnp.bmj.com\/content\/86\/4\/366.abstract<\/p>\n

 <\/p>\n

Seizure reduction in a low-grade glioma: more than a beneficial side effect of temozolomide<\/h1>\n
\n
    \n
  1. Johan A F Koekkoek<\/a><\/span>1<\/a>,<\/span>2<\/a>,<\/li>\n
  2. Linda Dirven<\/a><\/span>1<\/a>,<\/li>\n
  3. Jan J Heimans<\/a><\/span>1<\/a>,<\/li>\n
  4. Tjeerd J Postma<\/a><\/span>1<\/a>,<\/li>\n
  5. Maaike J Vos<\/a><\/span>2<\/a>,<\/li>\n
  6. Jaap C Reijneveld<\/a><\/span>1<\/a>,<\/li>\n
  7. Martin J B Taphoorn<\/a><\/span>1<\/a>,<\/span>2\n
    \n
    \n
    <\/div>\n
    J Neurol Neurosurg Psychiatry<\/a><\/abbr> <\/span> 2015;<\/span>86:<\/span><\/span>366-373 <\/span> doi:10.1136\/jnnp-2014-308136 <\/span> <\/cite><\/div>\n<\/div>\n<\/div>\n<\/li>\n<\/ol>\n<\/div>\n

    <\/p>\n","protected":false},"excerpt":{"rendered":"

    Low grade gliomas are associated with a higher frequency of seizures.\u00a0 While antieplipetic medications are utilized to reduced seizure frequency, in this issue of JNNP temozolomide was also associated with a a significant reduction in seizure frequency.\u00a0 Perhaps temozolomide should be added to therapy of LGGs with intractable seizures.   Read more at http:\/\/jnnp.bmj.com\/content\/86\/4\/366.abstract   […]<\/p>\n

    Read More…<\/a><\/p>\n","protected":false},"author":160,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-502","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"yoast_head":"\nTemozolomide reduces risk of seizures in low grade glioma! - JNNP blog<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/blogs.bmj.com\/jnnp\/2015\/04\/07\/temozolomide-reduces-risk-of-seizures-in-low-grade-glioma\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Temozolomide reduces risk of seizures in low grade glioma! - JNNP blog\" \/>\n<meta property=\"og:description\" content=\"Low grade gliomas are associated with a higher frequency of seizures.\u00a0 While antieplipetic medications are utilized to reduced seizure frequency, in this issue of JNNP temozolomide was also associated with a a significant reduction in seizure frequency.\u00a0 Perhaps temozolomide should be added to therapy of LGGs with intractable seizures.   Read more at http:\/\/jnnp.bmj.com\/content\/86\/4\/366.abstract   [...]Read More...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/blogs.bmj.com\/jnnp\/2015\/04\/07\/temozolomide-reduces-risk-of-seizures-in-low-grade-glioma\/\" \/>\n<meta property=\"og:site_name\" content=\"JNNP blog\" \/>\n<meta property=\"article:published_time\" content=\"2015-04-07T13:27:01+00:00\" \/>\n<meta name=\"author\" content=\"Steve Vucic, Web Editor\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Steve Vucic, Web Editor\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jnnp\\\/2015\\\/04\\\/07\\\/temozolomide-reduces-risk-of-seizures-in-low-grade-glioma\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jnnp\\\/2015\\\/04\\\/07\\\/temozolomide-reduces-risk-of-seizures-in-low-grade-glioma\\\/\"},\"author\":{\"name\":\"Steve Vucic, Web Editor\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jnnp\\\/#\\\/schema\\\/person\\\/5b9f797a427758da9d63182166e6458c\"},\"headline\":\"Temozolomide reduces risk of seizures in low grade glioma!\",\"datePublished\":\"2015-04-07T13:27:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jnnp\\\/2015\\\/04\\\/07\\\/temozolomide-reduces-risk-of-seizures-in-low-grade-glioma\\\/\"},\"wordCount\":113,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jnnp\\\/#organization\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/jnnp\\\/2015\\\/04\\\/07\\\/temozolomide-reduces-risk-of-seizures-in-low-grade-glioma\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jnnp\\\/2015\\\/04\\\/07\\\/temozolomide-reduces-risk-of-seizures-in-low-grade-glioma\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jnnp\\\/2015\\\/04\\\/07\\\/temozolomide-reduces-risk-of-seizures-in-low-grade-glioma\\\/\",\"name\":\"Temozolomide reduces risk of seizures in low grade glioma! - JNNP blog\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jnnp\\\/#website\"},\"datePublished\":\"2015-04-07T13:27:01+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jnnp\\\/2015\\\/04\\\/07\\\/temozolomide-reduces-risk-of-seizures-in-low-grade-glioma\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/jnnp\\\/2015\\\/04\\\/07\\\/temozolomide-reduces-risk-of-seizures-in-low-grade-glioma\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jnnp\\\/2015\\\/04\\\/07\\\/temozolomide-reduces-risk-of-seizures-in-low-grade-glioma\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/blogs.bmj.com\\\/jnnp\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Temozolomide reduces risk of seizures in low grade glioma!\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jnnp\\\/#website\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jnnp\\\/\",\"name\":\"JNNP blog\",\"description\":\"The official JNNP blog. A place to discuss wider neurology beyond the journal's monthly edition.\",\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jnnp\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/blogs.bmj.com\\\/jnnp\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jnnp\\\/#organization\",\"name\":\"JNNP blog\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jnnp\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jnnp\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jnnp\\\/files\\\/2017\\\/11\\\/blog-logo-jnnp1.png\",\"contentUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/jnnp\\\/files\\\/2017\\\/11\\\/blog-logo-jnnp1.png\",\"width\":427,\"height\":34,\"caption\":\"JNNP blog\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jnnp\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jnnp\\\/#\\\/schema\\\/person\\\/5b9f797a427758da9d63182166e6458c\",\"name\":\"Steve Vucic, Web Editor\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8e68076dae6fcffc1703a9f57f705b2f6f05335487da4d73145fa337d10c9b5a?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8e68076dae6fcffc1703a9f57f705b2f6f05335487da4d73145fa337d10c9b5a?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8e68076dae6fcffc1703a9f57f705b2f6f05335487da4d73145fa337d10c9b5a?s=96&d=mm&r=g\",\"caption\":\"Steve Vucic, Web Editor\"},\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jnnp\\\/author\\\/svucic\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Temozolomide reduces risk of seizures in low grade glioma! - JNNP blog","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/blogs.bmj.com\/jnnp\/2015\/04\/07\/temozolomide-reduces-risk-of-seizures-in-low-grade-glioma\/","og_locale":"en_US","og_type":"article","og_title":"Temozolomide reduces risk of seizures in low grade glioma! - JNNP blog","og_description":"Low grade gliomas are associated with a higher frequency of seizures.\u00a0 While antieplipetic medications are utilized to reduced seizure frequency, in this issue of JNNP temozolomide was also associated with a a significant reduction in seizure frequency.\u00a0 Perhaps temozolomide should be added to therapy of LGGs with intractable seizures.   Read more at http:\/\/jnnp.bmj.com\/content\/86\/4\/366.abstract   [...]Read More...","og_url":"https:\/\/blogs.bmj.com\/jnnp\/2015\/04\/07\/temozolomide-reduces-risk-of-seizures-in-low-grade-glioma\/","og_site_name":"JNNP blog","article_published_time":"2015-04-07T13:27:01+00:00","author":"Steve Vucic, Web Editor","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Steve Vucic, Web Editor","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/blogs.bmj.com\/jnnp\/2015\/04\/07\/temozolomide-reduces-risk-of-seizures-in-low-grade-glioma\/#article","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/jnnp\/2015\/04\/07\/temozolomide-reduces-risk-of-seizures-in-low-grade-glioma\/"},"author":{"name":"Steve Vucic, Web Editor","@id":"https:\/\/blogs.bmj.com\/jnnp\/#\/schema\/person\/5b9f797a427758da9d63182166e6458c"},"headline":"Temozolomide reduces risk of seizures in low grade glioma!","datePublished":"2015-04-07T13:27:01+00:00","mainEntityOfPage":{"@id":"https:\/\/blogs.bmj.com\/jnnp\/2015\/04\/07\/temozolomide-reduces-risk-of-seizures-in-low-grade-glioma\/"},"wordCount":113,"commentCount":0,"publisher":{"@id":"https:\/\/blogs.bmj.com\/jnnp\/#organization"},"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/blogs.bmj.com\/jnnp\/2015\/04\/07\/temozolomide-reduces-risk-of-seizures-in-low-grade-glioma\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/blogs.bmj.com\/jnnp\/2015\/04\/07\/temozolomide-reduces-risk-of-seizures-in-low-grade-glioma\/","url":"https:\/\/blogs.bmj.com\/jnnp\/2015\/04\/07\/temozolomide-reduces-risk-of-seizures-in-low-grade-glioma\/","name":"Temozolomide reduces risk of seizures in low grade glioma! - JNNP blog","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/jnnp\/#website"},"datePublished":"2015-04-07T13:27:01+00:00","breadcrumb":{"@id":"https:\/\/blogs.bmj.com\/jnnp\/2015\/04\/07\/temozolomide-reduces-risk-of-seizures-in-low-grade-glioma\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/blogs.bmj.com\/jnnp\/2015\/04\/07\/temozolomide-reduces-risk-of-seizures-in-low-grade-glioma\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/blogs.bmj.com\/jnnp\/2015\/04\/07\/temozolomide-reduces-risk-of-seizures-in-low-grade-glioma\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/blogs.bmj.com\/jnnp\/"},{"@type":"ListItem","position":2,"name":"Temozolomide reduces risk of seizures in low grade glioma!"}]},{"@type":"WebSite","@id":"https:\/\/blogs.bmj.com\/jnnp\/#website","url":"https:\/\/blogs.bmj.com\/jnnp\/","name":"JNNP blog","description":"The official JNNP blog. A place to discuss wider neurology beyond the journal's monthly edition.","publisher":{"@id":"https:\/\/blogs.bmj.com\/jnnp\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/blogs.bmj.com\/jnnp\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/blogs.bmj.com\/jnnp\/#organization","name":"JNNP blog","url":"https:\/\/blogs.bmj.com\/jnnp\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blogs.bmj.com\/jnnp\/#\/schema\/logo\/image\/","url":"https:\/\/blogs.bmj.com\/jnnp\/files\/2017\/11\/blog-logo-jnnp1.png","contentUrl":"https:\/\/blogs.bmj.com\/jnnp\/files\/2017\/11\/blog-logo-jnnp1.png","width":427,"height":34,"caption":"JNNP blog"},"image":{"@id":"https:\/\/blogs.bmj.com\/jnnp\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/blogs.bmj.com\/jnnp\/#\/schema\/person\/5b9f797a427758da9d63182166e6458c","name":"Steve Vucic, Web Editor","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/8e68076dae6fcffc1703a9f57f705b2f6f05335487da4d73145fa337d10c9b5a?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/8e68076dae6fcffc1703a9f57f705b2f6f05335487da4d73145fa337d10c9b5a?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8e68076dae6fcffc1703a9f57f705b2f6f05335487da4d73145fa337d10c9b5a?s=96&d=mm&r=g","caption":"Steve Vucic, Web Editor"},"url":"https:\/\/blogs.bmj.com\/jnnp\/author\/svucic\/"}]}},"_links":{"self":[{"href":"https:\/\/blogs.bmj.com\/jnnp\/wp-json\/wp\/v2\/posts\/502","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.bmj.com\/jnnp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.bmj.com\/jnnp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/jnnp\/wp-json\/wp\/v2\/users\/160"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/jnnp\/wp-json\/wp\/v2\/comments?post=502"}],"version-history":[{"count":0,"href":"https:\/\/blogs.bmj.com\/jnnp\/wp-json\/wp\/v2\/posts\/502\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.bmj.com\/jnnp\/wp-json\/wp\/v2\/media?parent=502"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.bmj.com\/jnnp\/wp-json\/wp\/v2\/categories?post=502"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.bmj.com\/jnnp\/wp-json\/wp\/v2\/tags?post=502"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}